There certainly are a lot of options for investors to choose from on the Australian share market.
But three that could be fantastic options right now are listed below. Here's what you need to know about them:
Image source: Getty Images
Goodman Group (ASX: GMG)
The first ASX share to consider buying is Goodman Group. It is a leading integrated commercial and industrial property company that owns a collection of high quality assets. It also has a significant development pipeline which will add to its portfolio during the coming years. Positively, many of Goodman's assets have exposure to structural tailwinds such as ecommerce and the digital economy. As a result, they look likely to be in demand with customers for a long time to come. This should be supportive of rental income and distribution growth over the next decade.
Macquarie is a fan of Goodman. It currently has an outperform rating and $26.63 price target on its shares.
ResMed Inc. (ASX: RMD)
Another ASX share to consider is ResMed. This sleep treatment-focused medical device company appears well-placed for growth during the 2020s thanks to its industry-leading products, sizeable market opportunity, and a major competitor product recall. ResMed also has a growing ecosystem of connected devices generating invaluable data insights. This could give it a real edge over the competition in the future and puts it in a great position to benefit from the shift to home healthcare.
This week Morgans put an add rating and $40.46 price target on the company's shares.
Xero Limited (ASX: XRO)
A final ASX share to look at is Xero. It provides small and medium sized businesses with a cloud-based business and accounting solution. It has been growing strongly over the last few years thanks to its international expansion, acquisitions, and the transition to the cloud. Positively, all these drivers are still in place and should be supported by its burgeoning app ecosystem. If the company can monetise this ecosystem and continue its international expansion, it could support strong revenue growth over the 2020s.
Goldman Sachs is bullish. The broker currently has a buy rating and $158.00 price target on its shares.
